Efficacy and Safety of MG-K10 in Adult Patients with Moderate-to-Severe Uncontrolled Asthma: Results From The Phase 2 Study.pdf
了解详情Efficacy and Safety of MG-K10 in Adult Patients with Moderate-to Severe Uncontrolled Asthma: Results From The Phase 2 Study.pdf
了解详情MG-K10 significantly improved clinical signs across all anatomical regions inadults with moderate-to-severe atopic dermatitis.pdf
了解详情Enhanced powder dispersion of dual-excipient spray-dried powder for mulations of a monoclonal antibody and its fragment for local treatment of severe asthma.pdf
了解详情Efficacy and Safety of MG-K10 in Adult Patients with Moderate-to-SevereAtopic Dermatitis: Results From The Phase 2 Study.pdf
了解详情Spray‑Dried and Spray‑Freeze‑Dried Powder Formulations of an Anti‑Interleukin‑4Rα Antibody for Pulmonary Delivery.pdf
了解详情版权所有 湖南麦济生物技术股份有限公司 © 2018-2024 mabge.com, All Rights Reserved
